As you can imagine, the frequency of injections drops way down
Important safety warnings seek urgent medical attention if you experience: Severe or persistent abdominal pain, which may radiate to the back this could indicate pancreatitis , a serious but rare risk associated with GLP-1based therapies as a class [16] [17] Right upper quadrant pain, fever, or jaundice these may suggest gallbladder disease , another class-associated risk Signs of dehydration (dizziness, reduced urine output, extreme thirst) resulting from severe vomiting or diarrhoea, which can affect kidney function Pregnancy and breastfeeding: Use of GLP-1based therapies and related investigational agents is not recommended during pregnancy or breastfeeding
The doses approved by regulatory bodies have been determined through rigorous phase III clinical trials involving thousands of participants, with careful assessment of both efficacy and safety profiles
HerskindAMMcGueMHolmNVSrensenTIHarvaldBVaupelJW
If you are found to have a Vitamin B12 deficiency diagnosed through blood tests, or if you have medical conditions that impede your bodys ability to absorb Vitamin B12, such as pernicious anemia, celiac disease, or Crohns disease, you could potentially qualify for these injections